Protalix Biotherapeutics to Present at Oppenheimer Annual Healthcare Conference and at Barclays Capital Small & Mid-Cap Health Care Conference

CARMIEL, Israel--(BUSINESS WIRE)--Protalix BioTherapeutics, Inc. (Amex: PLX), announced today that Dr. David Aviezer, President and Chief Executive Officer, will present at the 19th Annual Oppenheimer Healthcare Conference on Monday, November 3, 2008, at 4:00 PM EDT. The conference is being held at the Waldorf Astoria Hotel in New York City.
MORE ON THIS TOPIC